Drugs / MenPF-1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01640652 | Aug 2012 → Jul 2013 | meningococcal infection | University of Oxford | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MenPF-1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01640652 ↗ |
| Modality | Vaccine | “MenPF-1 is a type of vaccine known as an Outer Membrane Vesicle (OMV) vaccine.” NCT01640652 ↗ |
| Route | Intramuscular | “Three doses of 25 μg or 50 μg of MenPF-1 were delivered intra-muscularly to 52 healthy adults.” PMID 25982025 ↗ May 2015 |